Advertisement

Drugs & Therapy Perspectives

, Volume 35, Issue 12, pp 619–620 | Cite as

Vitamin D with calcium supplements: a new hope for the treatment of dengue infection

  • Muhammad Torequl IslamEmail author
Letter to the Editor
  • 36 Downloads

Dengue, a mosquito-borne viral infection, is one of the major public health problems in tropical and sub-tropical areas worldwide. Dengue virus (DENV) is transmitted by the female mosquito, Aedes spp., mainly by Ae. aegypti and Ae. albopictus [1]. However, Ae. polynesiensis and Ae. niveus have been reported as two more secondary vectors in some regions of the world [2]. Recently, it has been seen that a deficiency of vitamins B12 and D may cause pyrexia of unknown origin, hemolytic anemia, and thrombocytopenia in humans [3]. A correlation has been seen between the wild-type AA MBL2 genotype and age as associated risk factors for development of DENV-related thrombocytopenia [4]. Severe dengue disease is associated with high viral loads and overproduction of pro-inflammatory cytokines, suggesting impairment in the control of DENV and the mechanisms that regulate production of cytokines (e.g., tumor necrosis factor-α, and interleukin-1β, -6, -12p70, -10, and -4) [5, 6, 7, 8].

It has been...

Notes

Compliance with ethical standards

Funding

No sources of funding were declared.

Conflict of interest

The author declares that he has  no competing interests.

References

  1. 1.
    Lin RJ, Lee TH, Leo YS. Dengue in the elderly: a review. Expert Rev Anti Infect Ther. 2017;15(8):729–35.CrossRefGoogle Scholar
  2. 2.
    Zahoor MK, Rasul A, Zahoor MA, et al. Dengue fever: a general perspective, chapter 1. In: Falcón-Lezama JA, Betancourt-Cravioto M, Tapia-Conyer R, editors. Dengue fever: a resilient threat in the face of innovation. London: IntechOpen; 2019.Google Scholar
  3. 3.
    Mishra VA, Harbada R, Sharma A. Vitamin B12 and vitamin D deficiencies: an unusual cause of fever, severe hemolytic anemia and thrombocytopenia. J Family Med Prim Care. 2015;4(1):145–8.CrossRefGoogle Scholar
  4. 4.
    Acioli-Santos B, Segat L, Dhalia R, et al. MBL2 gene polymorphisms protect against development of thrombocytopenia associated with severe dengue phenotype. Hum Immunol. 2008;69(2):122–8.CrossRefGoogle Scholar
  5. 5.
    Arboleda Alzate JF, Rodenhuis-Zybert IA, Hernández JC, et al. Human macrophages differentiated in the presence of vitamin D3 restrict dengue virus infection and innate responses by downregulating mannose receptor expression. PLoS Negl Trop Dis. 2017;11(10):e0005904.CrossRefGoogle Scholar
  6. 6.
    Giraldo DM, Cardona A, Urcuqui-Inchima S. High-dose of vitamin D supplement is associated with reduced susceptibility of monocyte-derived macrophages to dengue virus infection and pro-inflammatory cytokine production: an exploratory study. Clin Chim Acta. 2018;478:140–51.CrossRefGoogle Scholar
  7. 7.
    Jadhav NJ, Gokhale S, Seervi M, et al. Immunomodulatory effect of 1, 25 dihydroxy vitamin D3 on the expression of RNA sensing pattern recognition receptor genes and cytokine response in dengue virus infected U937-DC-SIGN cells and THP-1 macrophages. Int Immunopharmacol. 2018;62:237–43.CrossRefGoogle Scholar
  8. 8.
    Khan RA, Afroz S, Minhas G, et al. Dengue virus envelope protein domain III induces pro-inflammatory signature and triggers activation of inflammasome. Cytokine. 2019;123:154780.CrossRefGoogle Scholar
  9. 9.
    de Almeida JP, Liberatti LS, Barros FE, et al. Profile of oxidative stress markers is dependent on vitamin D levels in patients with chronic hepatitis C. Nutrition. 2016;32(3):362–7.CrossRefGoogle Scholar
  10. 10.
    Rai V, Abdo J, Agrawal S, et al. Vitamin D receptor polymorphism and cancer: an update. Anticancer Res. 2017;37(8):3991–4003.PubMedGoogle Scholar
  11. 11.
    Laplana M, Royo JL, Fibla J. Vitamin D receptor polymorphisms and risk of enveloped virus infection: a meta-analysis. Gene. 2018;678:384–94.CrossRefGoogle Scholar
  12. 12.
    Arboleda JF, Urcuqui-Inchima S. Vitamin D-regulated microRNAs: are they protective factors against dengue virus infection? Adv Virol. 2016;2016:1016840.CrossRefGoogle Scholar
  13. 13.
    Arboleda JF, Fernandez GJ, Urcuqui-Inchima S. Vitamin D-mediated attenuation of miR-155 in human macrophages infected with dengue virus: implications for the cytokine response. Infect Genet Evol. 2019;69:12–21.CrossRefGoogle Scholar
  14. 14.
    Sánchez-Valdéz E, Delgado-Aradillas M, Torres-Martínez JA, et al. Clinical response in patients with dengue fever to oral calcium plus vitamin D administration: study of 5 cases. Proc West Pharmacol Soc. 2009;52:14–7.PubMedGoogle Scholar
  15. 15.
    Zaloga GP, Chernow B. The multifactorial basis for hypocalcemia during sepsis: studies of the parathyroid hormone–vitamin D axis. Ann Intern Med. 1987;107(1):36–41.CrossRefGoogle Scholar
  16. 16.
    Dhawan R, Chaturvedi UC, Khanna M, et al. Obligatory role of Ca2+ in the cytotoxic activity of dengue virus-induced cytotoxin. Int J Exp Pathol. 1991;72(1):31–9.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Chaturvedi P, Saxena V, Dhawan R. Role of calcium in induction of dengue virus-specific helper T cells. Indian J Exp Biol. 1995;33:809–15.PubMedGoogle Scholar
  18. 18.
    Misra A, Mukerjee R, Chaturvedi UC. Production of nitrite by dengue virus-induced cytotoxic factor. Clin Exp Immunol. 1996;104(3):406–11.CrossRefGoogle Scholar
  19. 19.
    Shivanthan MC, Rajapakse S. Dengue and calcium. Int J Crit Illn Inj Sci. 2014;4(4):314–6.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Pharmacy, Life Science FacultyBangabandhu Sheikh Mujibur Rahman Science and Technology UniversityGopalganjBangladesh

Personalised recommendations